Clinical Trials Browser

Phase 3 × Completed × darolutamide × Clear all

NCT04736199 2026-02-27

ARANOTE

Phase 3 Completed

669 enrolled 16 charts

Prostatic Neoplasms

NCT02200614 2022-06-28

ARAMIS

Phase 3 Completed

1,509 enrolled 13 charts 1 FDA

Prostate Cancer Non-Metastatic